+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 8 Actively Recruiting clinical trials

S

Actively Recruiting

This research aims to find out how common cardiac amyloidosis is among older adults aged 80 years and above who have been hospitalized for heart failure and show thickening of the hearts left ventricle. The study is observational and conducted across multiple geriatric and cardiology centers. It focuses on patients who have experienced heart failure with specific heart muscle changes seen on echocardiography. Participants will be recruited over 24 months and followed for 12 months. At the start, researchers will collect medical history, demographic information, clinical data, frailty status, biological and genetic tests, and echocardiogram results. Bone scans using specific tracers will be performed during or after hospital stays to check for heart muscle involvement. Follow-up will include phone calls every three months to track hospitalizations, care facility admissions, and survival. During the study, participants will have regular assessments including frailty scales, cognitive tests, and questionnaires related to neuropathic pain and independence in daily activities. Researchers will evaluate bone scan results to detect amyloidosis and measure other health and functional outcomes. The study aims to provide a clearer picture of cardiac amyloidosis prevalence and patient condition over one year.

Age: 80Years +All Genders
36 locations
E

Actively Recruiting

Researchers are evaluating two psycho-physical interventions for people with moderate to severe alcohol use disorder AUD to reduce heavy drinking days and prevent relapse. The study compares Mindfulness Based Relapse Prevention MBRP, a structured program involving mindfulness practice, with an unguided meditative relaxation program. This research addresses the need for effective therapies in AUD, as only a small percentage of patients receive approved drugs, and some patients are resistant to cognitive behavioral therapies. Participants will be randomly assigned to either the MBRP group or a relaxationmeditation control group. MBRP involves seven sessions lasting 60 to 120 minutes each, covering topics such as triggers, relapse prevention, and mindfulness in daily life, including meditation exercises and discussions on at-home practice. The relaxation group attends seven sessions of unguided relaxation with nature sounds, accommodating up to 12 participants per group. Throughout the study, participants will be monitored for changes in heavy drinking days, alcohol consumption, craving frequency and strength, anxiety, depression, quality of life, emotion regulation, impulsivity, coping mechanisms, and cognitive impairment over 3, 6, and 12 months. Researchers will track the number of meditation sessions and assess mental health and behavioral changes. The primary outcome is the reduction in heavy drinking days six months after inclusion, with continued evaluations up to one year.

Age: 18Years +All GendersPhase Not Applicable
7 locations
I

Actively Recruiting

Researchers are evaluating the impact of the EDIT-B4 blood test on patients experiencing a Major Depressive Episode MDE, which can occur in Major Depressive Disorder or bipolar disorder. Bipolar disorder affects about 2% of people worldwide and is often misdiagnosed, leading to delayed treatment and increased suicide risk. This study aims to measure how using EDIT-B4 affects patient management and health outcomes, including economic aspects, over six months. Participants are randomly assigned to one of two groups one where the physician receives the EDIT-B4 test results to guide treatment, and another where the test is performed but results are not shared until the study ends. The EDIT-B4 test involves taking a 2.5 ml blood sample analyzed using RNA sequencing and AI algorithms to differentiate bipolar disorder from major depression. The study involves four visits over six months to monitor changes. During the study, participants depressive symptoms are assessed at inclusion and again at 15-16 weeks to evaluate improvement. Researchers collect data on symptom changes, treatment adjustments, and health economics. The trial will monitor safety and effectiveness of using the test to guide care. Participation requires attending scheduled visits and following the study protocol, with the total involvement lasting about six months.

Age: 18Years - 65YearsAll GendersPhase Not Applicable
7 locations
U

Actively Recruiting

Sarcopenia is a progressive muscle disorder common in older adults, characterized by loss of muscle mass, strength, and physical performance. This condition increases risks of falls, frailty, and mortality. Researchers are exploring the use of high-definition surface electromyography HD-sEMG to develop a new, non-invasive diagnostic method for sarcopenia. The study targets people aged 75 and older who are hospitalized and suspected of having sarcopenia based on a screening questionnaire score. Participants will undergo HD-sEMG to record muscle activation signals from the rectus femoris muscle during knee movements or chair rises. Additional assessments include body composition via bioimpedancemetry and possibly DEXA scans, muscle strength tests using handgrip measurements, and physical performance evaluations. The study is descriptive and cross-sectional, conducted across multiple centers, with a planned inclusion period of 18 months and a 3-month follow-up after inclusion. Throughout the study, participants will provide data through muscle ultrasound and physical activity questionnaires. Researchers will analyze HD-sEMG signals to differentiate between sarcopenic and non-sarcopenic individuals and to monitor functional recovery and muscle parameters over time. Outcomes include correlations with muscle mass, strength, physical performance, and quality of life. The total study duration is 21 months, with assessments conducted from day 1 through day 90 after inclusion.

Age: 75Years +All GendersPhase Not Applicable
11 locations
E

Actively Recruiting

Researchers are studying ways to improve how well adult patients with chronic diseases follow their treatment plans. The study aims to increase adherence to therapy by 15% over six months by using a simple, standardized, and repeated message delivered by trained healthcare professionals. This approach is designed to help patients better manage their treatments without changing their prescribed medications. In this trial, healthcare professionals provide patients with a clear 3-point message focused on boosting therapeutic adherence. This message is delivered during patient consultations after the professionals have been trained. The study uses a stepped-wedge design where some patients receive usual care before the message delivery begins, followed by an intervention period where the message is given repeatedly by various healthcare providers involved in the patients hospital care. The delivery of the message is tracked using a checklist. Participants are involved by completing a self-questionnaire about their treatment adherence, helping them engage actively in managing their care. The study measures improvements in adherence at six and twelve months, along with factors predicting better adherence, costs of care, intervention costs, and healthcare professionals satisfaction. The research will help guide better patient care practices and optimize treatment benefits while reducing healthcare resource waste.

Age: 18Years +All GendersPhase Not Applicable
10 locations
O

Actively Recruiting

This research is focused on evaluating the feasibility of conducting initial screening for bronchopulmonary cancer using chest CT scans in a French population within a coordinated and efficient network at pilot centers. The study aims to organize bronchopulmonary cancer screening in the Ile de France region through a clear and functional process, including eligibility criteria based on the NELSON study, and coordinated referrals for consultations, CT scans, and follow-up care. Participants undergo screening CT scans according to the NELSON trial schedule at inclusion, 1 year, 3 years, and 5.5 years. The screening process includes referral by trained physicians, structured centralized reading of CT images, multidisciplinary team review for suspected cancers, referral to smoking cessation programs for current smokers, and organized follow-up within the screening program. During the study, participants will complete an online self-questionnaire and attend an inclusion visit at a health center. Researchers will assess completion rates of CT scans at specified time points, smoking cessation rates, detection rates of early-stage bronchopulmonary cancers, and rates of complications related to further examinations. The primary outcome includes the rate of initial CT scans for screening over 36 months, with ongoing monitoring and follow-up planned through 5.5 years. The total study duration extends until 2034.

Age: 50Years - 74YearsAll GendersPhase Not Applicable
9 locations
C

Actively Recruiting

Depression affects about 17% of people during their lifetime, with many cases becoming resistant to treatment. Treatment-resistant depression TRD often leads to relapse, recurrence, and reduced quality of life, impacting daily functioning and healthcare needs. This trial explores the use of Vagus Nerve Stimulation VNS as a new treatment option for patients with TRD, including those with bipolar disorder, aiming to address the limitations of current therapies like electroconvulsive therapy ECT. The study is a national, multicenter, randomized, controlled trial comparing VNS plus optimal medical treatment to optimal medical treatment alone. Participants will be randomly assigned to either receive VNS along with the best medical treatment BMT or BMT alone. The VNS device is surgically implanted under general anesthesia, involving electrode placement on the vagus nerve and a stimulator under the skin. Following implantation, stimulation settings are adjusted over several months to reach therapeutic levels. Both groups will be followed for 24 months with regular visits, including medical and psychiatric evaluations, while the experimental group undergoes additional neurosurgical and stimulation adjustment visits. Throughout the study, participants will attend multiple scheduled visits for clinical assessments, including evaluations of depression severity, treatment effects, and safety monitoring. Data on cost-utility and efficacy of VNS will be collected at various intervals up to 24 months. The study aims to provide insight into the long-term benefits and economic impact of VNS compared to standard care for treatment-resistant depression.

Age: 18Years +All GendersPhase Not Applicable
24 locations
S

Actively Recruiting

Severe acute respiratory infections SARIs are a major cause of hospitalization and death worldwide, especially affecting older adults and individuals with other health conditions. These infections are often caused by viruses such as influenza, respiratory syncytial virus, parainfluenza viruses, adenoviruses, rhinoviruses, and emerging viruses like SARS-CoV-2. Age-related weakening of the immune system increases the risk of severe illness and related complications. This study aims to identify the proportion of viral respiratory infections in hospitalized patients aged 60 years and older confirmed by polymerase chain reaction PCR. This observational study will recruit older hospitalized patients who have undergone respiratory viral sampling using RT-PCR as part of their standard care. Recruitment will take place over 24 months at about 20 centers, with each participant followed for three months. Respiratory samples such as nasal or nasopharyngeal swabs, or bronchoalveolar lavage fluid, will be analyzed locally to detect respiratory viruses responsible for the infection. Participants will have one initial inclusion visit during hospitalization and then receive follow-up phone calls for three months after discharge. The study will collect information on viral infections, patient characteristics, vaccination status, co-infections, and hospital burden related to respiratory viruses. Researchers will monitor epidemiological trends and patients health outcomes while ensuring data collection aligns with routine care. This study is expected to provide detailed insight into viral respiratory infections in older adults.

Age: 60Years +All Genders
20 locations